Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
|
IN |
|
Aspial Corporation Ltd
SGX:A30
|
SG |
|
W
|
Walt Disney Co
XMUN:WDP
|
US |
Wall Street
Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 263.43 INR with a low forecast of 1 515.41 INR and a high forecast of 2 871.75 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GLENMARK's stock price target?
Price Target
2 263.43
INR
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 263.43 INR with a low forecast of 1 515.41 INR and a high forecast of 2 871.75 INR.
What is Glenmark Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
11%
For the last 13 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's revenue is 10%. The projected CAGR for the next 3 years is 11%.
What is Glenmark Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
24%
For the last 13 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's operating income is 9%. The projected CAGR for the next 3 years is 24%.
What is Glenmark Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
38%
For the last 13 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's net income is 7%. The projected CAGR for the next 3 years is 38%.
